Equity search
Top stocks
Moje portfolio
Set Favorites, set Portfolio
Oblíbené tituly
select
NameBest
buy		Best
sell		Change
(%)
ČEZ12471248-0.48
KB985.59860.25
PKN145.7145.761.15
Msft397.37397.70.00
Nokia11.7411.750.17
IBM272.56273.25-1.62
Mercedes-Benz Group AG47.44547.450.70
PFE25.6125.63-0.39
11/06/2026 13:44:00
Real-Time data
Indices online
PX
Further equity indices

AD index online
select
AD index online
Patria Direct
Patria DirectThings our clients appreciate most: A large and experienced team of professional brokers, customer care support, stable and secure trading platform, unique news and information service. Try our demo account and see for yourself.

Free services: Patria Plus news services, analytical reports, account opening and keeping, submitting and cancelling orders, FX conversions. Moreover, for active traders we also offer free real-time data and Investor Plus services.
 

  • 10/06/2026
Corcept Thera (NASDAQ Cons)
Close at 10.6.2026 Change (%) Change (USD) Turnover (pcs)
78.12 0.81 0.63 1,494,456
Premarket11/06/2026 13:31:45
Last trade Nákup / Prodej Change (%) Change (USD) Turnover (pcs)
78.28 74.00 80.51 0.20 0.16 208
R - Real-Time data can be activated by Patria Plus / Investor Plus clients HERE.

Actions
Buy / Sell - Trial portfolio
Add to my favorites
Set SMS / E-Mail alert
Analytical service
Historical data
 
  • Účetní období do: 31/03/2026
Next Economy Results
Market capitalization 8,039.56 mil. USD Hrubá marže (12M klouzavě) 98.25%
Celkové tržby (12M klouzavě) 769.10 mil. USD Návratnost vlastního jmění (ROE, 12M klouzavě) 7.17
EBITDA (12M klouzavě) -6.76 mil. USD Cena/tržby na akcii (12M klouzavě) 10.45
Čistý zisk pro akcionáře (12M klouzavě) 47.34 mil. USD P/E bez mimořádných položek (12M klouzavě) 211.15
Zisk na akcii (EPS, 12M klouzavě) 0.35 P/BV (poslední čtvrtletí) 12.60
Tržby na akcii (12M klouzavě) 6.62 Enterprise Value 7,696.14 mil. USD
Účetní hodnota na akcii (BV, poslední čtvrtletí) 5.94 Cash-flow na akcii (12M klouzavě) 0.42
Hotovost na akcii (poslední čtvrtletí) 3.20 Dividenda na akcii (12M klouzavě) 0.00
Source: Reuters
Currency: USD
On mouse over for description.
  • Latest update: 09/05/2026
Financial results 
select
select
Submit
 2025/12025/22025/32025/42026/1
Cash & Equivalents90103125120109
Short Term Investments235242299257235
Cash and Short Term Investments325345424377343
Accounts Receivable - Trade, Net6265706039
Total Receivables, Net6265706039
Total Inventory1412121313
Prepaid Expenses910232320
Other Current Assets, Total2912121211
Total Current Assets439443541485426
Property/Plant/Equipment, Total - Net877610
Long Term Investments248173103160177
Other Long Term Assets, Total152179173184201
Total Assets846802824837815
Accounts Payable2824344033
Accrued Expenses115121138126116
Notes Payable/Short Term Debt00000
Total Current Liabilities143145172166149
Total Long Term Debt00000
Total Debt00000
Other Liabilities, Total2021192328
Total Liabilities163166192189177
Preferred Stock - Non Redeemable, Net00000
Common Stock00000
Additional Paid-In Capital8639019349691,002
Retained Earnings (Accumulated Deficit)564599619643612
Treasury Stock - Common-745-867-923-967-977
Other Equity, Total12221
Total Equity683636632648638
Total Liabilities & Shareholders’ Equity846802824837815
Total Common Shares Outstanding106105105106107
Last annual results 31/12/2025
Last interim results 31/03/2026
 
Fiscal period: Annual Fiscal period: Interim
Last fiscal year: 2025 Fiscal year: 2026
End of fiscal year: 31/12/2025 End of interim fiscal: 31/03/2026
Auditor name: Ernst & Young LLP Period length: -
Period length: -
Source: Reuters
Currency: USD
  • Latest update: -
Basic Factors
This service is only available to Patria Plus and Investor Plus subscribers. If you are a Patria Plus or Investor Plus client, please log in.
Economy Result Estimates
This service is only available to Patria Plus and Investor Plus subscribers. If you are a Patria Plus or Investor Plus client, please log in.